GSK-49653/143



A 24-Week Randomized, Double-blind Study to Evaluate the Efficacy, Safety and Tolerability of AVANDIA (8mg once daily) in Combination with Glyburide in African American and Hispanic Patients with Type 2 Diabetes Mellitus who are Inadequately Controlled on Glyburide Monotherapy
rosiglitazone
49653/143
NCT00333723
Diabetes Mellitus, Type 2
Phase 4
 
February 2015